Endocan Announces Closing of Financing
September 23, 2021 at 16:08 PM EDT
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2021) - Endocan Solutions Inc. ("Endocan" or the "Company") announces that it has completed a non-brokered private placement of 1,914,529 shares at a price of $0.35 per share for net proceeds of $670,085.00. The Company will use the net proceeds from the Financing to fund operations. The Shares issued will be subject to a statutory four month hold period.
About Endocan Solutions Inc.
Listing Statement and Caution
On behalf of the Board of Directors,
Mr Bruce Clark
For further information, please contact the Company at:
Tel.: (604) 401-8100
This news release may include forward-looking information that is subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking information are based on reasonable assumptions, such information is not a guarantee of future performance and actual results or developments may differ materially from those contained in forward-looking information. Factors that could cause actual results to differ materially from those in forward-looking information include, but are not limited to, fluctuations in market prices, successes of the operations of the Company, continued availability of capital and financing and general economic, market or business conditions. There can be no assurances that such information will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. The Company does not assume any obligation to update any forward-looking information except as required under the applicable securities laws.
Neither the CSE nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/97449